Today during trading, Aptose Biosciences Inc shares closed at $1.75 after opening the day at $1.85. Intraday prices ranged from $1.74 to $1.85.

The price $verbed percentage_change% from the previous day's close of $1.75.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Aptose Biosciences Inc traded under APS on the Toronto Stock Exchange (TSX).

A total of 10,978 shares was traded during the session, with total trades of 69, while having an average volume of 11,319 over 5 days.

The TSX market on the whole today saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, APS.TO has traded as high as $11.40 (May 02,2023) and low as $1.71 (April 16,2024). Moreover, the shares have plummeted -83.09 percent in 52 weeks, while in 2024, they have plummeted -47.76%.

Following today's trading, Aptose Biosciences Inc has a market capitalization of $27.50 million on a float of 15,718 shares outstanding. Its annual EPS is $-7.58.

Aptose Biosciences Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Aptose Biosciences Inc's average recommendation is "Strong Buy" based on 3.00 analysts according to Zacks. Currently, there are 3 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..